Page last updated: 2024-11-04

sulfamonomethoxine and Colorectal Neoplasms

sulfamonomethoxine has been researched along with Colorectal Neoplasms in 1 studies

Sulfamonomethoxine: Long acting sulfonamide antibacterial agent.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamiyama, S1
Ichimiya, T1
Ikehara, Y1
Takase, T1
Fujimoto, I1
Suda, T1
Nakamori, S1
Nakamura, M1
Nakayama, F1
Irimura, T1
Nakanishi, H1
Watanabe, M1
Narimatsu, H1
Nishihara, S1

Other Studies

1 other study available for sulfamonomethoxine and Colorectal Neoplasms

ArticleYear
Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma.
    Glycobiology, 2011, Volume: 21, Issue:2

    Topics: Anion Transport Proteins; Biological Transport; Cell Proliferation; Colorectal Neoplasms; Drug Combi

2011